Advancis: Funds Through Early 2006  NEW YORK (Reuters) - Advancis Pharmaceutical Corp.  &lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=AVNC.O target=/stocks/quickinfo/fullquote"&gt;AVNC.O&lt;/A&gt;, which recently saw a large contract end with  GlaxoSmithKline Plc &lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=GSK.L target=/stocks/quickinfo/fullquote"&gt;GSK.L&lt;/A&gt;, said Friday it has enough funds to  operate though at least early 2006, and outlined a plan to cut  costs.